Congenital nasolacrimal duct obstruction (CNLDO) is a common disorder that affects approximately 6-20% of children in the first year of their life. Here we present a case of bilateral congenital dacryocystoceles infected with Serracia marcescens. A 50 day old male infant, born by caesarean section at term, presented to the clinic with a swelling and hyperemia on the region of the left lacrimal sac for 3 days, with a purulent discharge coming from both eyes. He had bilateral probing, irrigation and nasolacrimal tube silicone intubation under general anesthesia. During this procedure a heavy pus kept on coming from both canals and the ruptured area. This material was cultured in blood, MacConkey, and chocolate agar. S.marcescens was isolated which was shown to be susceptible to piperacillin, tazobactam, ceftazidim, cefepim, aztreonam, imipenem, meropenem, amikacin, gentamicin, tobramycin, ciprofloxacin, levofloxacin, tigecycline, trimethoprim-sulfamethoxazole; but resistant to netilmycin and colistin. The symptoms resolved in a week and the antibiotics were stopped. Conservative approach including gentle massage and warm compresses with topical antibiotics are recommended in the management of congenital dacryocystocoeles. If it progresses to acute dacryocystitis,  intravenous antibiotics are indicated to prevent fatal complications like meningitis, brain abscess and sepsis. In case of failure of probing, extensive marsupialization of the cyst, silicone tube implantation or balloon dacryocystoplasty is recommended.

Keywords - Serracia marcescens, dacryocystocele

1. Nesi FA, Lishman RD, Levine MR. Ophthalmic plastic and reconstructive surgery. 2nd ed. Congenital lacrimal disorders. St.Louis: Mosby-Year Book, Inc.; 1998.
2. Vagge A, Ferro Desideri L, Nucci P, Serafino M, Giannaccare G, Lembo A, Traverso CE.Congenital Nasolacrimal Duct Obstruction (CNLDO):A Review. Diseases. 2018 Oct 22;6(4).
3. Becker BB. The treatment of congenital dacryocystocele. Am J Ophthalmol 2006;142:835-838.
4. Wong RK, VanderVeen DK. Presentation and management of congenital dacryocystocele. Pediatrics 2008;122:e1108-e1112.
5. Al-Faky YL, Naeem T, Al-Sobaie N, Al-Huthail R, Al-Odan H, Osman EA, et al. Value of microbiology study in congenital nasolacrimal duct obstruction. Saudi J Ophthalmol 2012;26: 223-8.
6. Ewete T, Alabi AS.Serratia marcescens Lacrimal Canaliculitis. Ophthalmology Research: An International Journal 6(2): 1-4, 2016.
7. Parment PA. The role of Serratia marcescens in soft contact lens associated ocular infections. Acta Ophthalmol. Scand. 1997: 75: 67-71.
8. MacEwen CJ, Young JD. Epiphora during the first year of life. Eye 1991, 5, 596–600.
9. Cavazza S, Laffi GL, Lodi L, Tassinari G, Dall'Olio.Acta Otorhinolaryngol Ital. 2008 Dec;28(6):298-301. Congenital dacryocystocele: diagnosis and treatment. Congenital Dacryocystocele: diagnosis and treatment. Acta Otorhinolaryngol Ital 2008;28:298-301.